跳至主要内容
临床试验/NCT04432818
NCT04432818已完成不适用

Digital Life Coaching in Multiple Myeloma Patients Undergoing Hematopoietic Stem Cell Transplantation

University of California, San Francisco2 个研究点 分布在 1 个国家目标入组 17 人开始时间: 2020年5月20日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
17
试验地点
2
主要终点
Number of participants displaying ongoing engagement with DLC

研究概览

简要总结

This is the first study of digital life coaching (DLC) to engage patients during the peri-HCT period that is punctuated by intensive life changes. DLC may circumvent these limitations by combining the integrative cross-dimensional nature of life coaching with the advantages of mobile health technology. The purpose of this study is to evaluate whether ongoing participant engagement with a DLC platform is feasible for multiple myeloma (MM) patients actively undergoing hematopoietic stem cell transplantation (HCT).

详细描述

Participants will receive unlimited access to Pack Health's DLC platform during a 16-week period encompassing pre-HCT conditioning chemotherapy, post-HCT recovery, and 100-day follow-up. Participants will engage with Pack Health's DLC platform and complete quality of life assessments for 16 weeks beginning from enrollment. At the conclusion of the treatment period, participants will be asked to rate their satisfaction with the DLC platform

Primary Objective:

To evaluate the rate of ongoing participant engagement with a DLC platform during the study period

Secondary Objectives:

  • To assess quality of life among participants during the study period
  • To assess psychosocial distress among participants during the study period
  • To assess sleep disturbances among participants during the study period
  • To assess participant satisfaction with the DLC platform at the end of the study period

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Confirmed diagnosis of one of the following (all referred to as MM in this protocol):
  • Multiple myeloma (ICD-10 code: C90.0)
  • Extramedullary plasmacytoma (ICD-10 code: C90.2)
  • Planned receipt of autologous HCT at our institution
  • Patients undergoing outpatient HCT will be eligible
  • Patients who received chemomobilization will be eligible
  • Age ≥ 18, as life coaches employed by the DLC vendor are not currently trained to work with pediatric patients

排除标准

  • Prior autologous HCT for any indication
  • Physician-assessed lack of sufficient English proficiency
  • Lack of ownership of a personal smartphone
  • Any serious and/or unstable pre-existing medical, psychiatric, or other condition that could interfere with participant's safety, provision of informed consent, or compliance with study procedures

结局指标

主要结局

Number of participants displaying ongoing engagement with DLC

时间窗: Up to 16 weeks

Ongoing participant engagement is defined as at least 4 or more participant-initiated interactions with the DLC platform, including at least 1 interaction in each of four 4-week study sub-periods

次要结局

  • Median National Comprehensive Cancer Network (NCCN) Distress Thermometer (DT) Score(Up to 16 weeks)
  • Median PRO Measurement Information System (PROMIS) Global Health (GH) Score(Up to 16 weeks)
  • Median Participant Satisfaction Score(Up to 16 weeks)
  • Median PROMIS Sleep Disturbance (SD) Short Form (SF) 4a Score(Up to 16 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验